HOTH
HOTH
NASDAQ · Pharmaceuticals

Hoth Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$0.90
+0.02 (+1.77%)
As of Mar 25, 5:35 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +188.2% upside
Low Target $1.73
Average Target $2.60
High Target $4.05
Current Price $0.90
Current
$0.90
Target
$2.60
$1.73 $2.60 avg $4.05
Scenario Analysis
Bear Case
$1.73
91.8%
Low target
Base Case
$2.60
+188.2%
Avg target
Bull Case
$4.05
+349.0%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$2.12
-57.4% from high
52-Week Low
$0.66
+37.6% from low
Target vs 52W High
$2.60
+22.9% vs high
Next Earnings Report
Mar 26, 2026 · After Market Close
Today
EPS Est: $-0.10
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%